Back

High use of direct oral anticoagulants in elderly patients with non valvular atrial fibrillation: results of REFLEJA study

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Cardiovascular Disease in Special Populations, miscellaneous Cardiovascular Disease in the Elderly ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Javier Torres Llergo

Jaen University Hospital, Jaen (Spain)

18 More presentations in this session

Presentation thumbnail
Associate Professor P. Rainer (St Johann in Tirol, AT)
Abstract Slides
Presentation thumbnail
Doctor K. Piddock (Manchester, GB)
Abstract
Presentation thumbnail
Doctor A. Bjerring (Oslo, NO)
Abstract Slides
Presentation thumbnail
Doctor S. Ooshima (Nagoya, JP)
Abstract
Presentation thumbnail
Doctor S. Okuno (Amagasaki, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Cardiovascular Disease in Special Populations, miscellaneous

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Direct oral anticoagulant rivaroxaban in very old and frail patients: A one-year prospective follow-up of a large-scale cohort (SAFIR-AC)
31 August 2019
thumbnail
Congress Presentation
Atrial fibrillation and acute coronary syndromes in nonagenarians
18 March 2022
thumbnail
Congress Presentation
Deprescribing in older patients with chronic heart failure and atrial fibrillation
29 June 2021
thumbnail
Congress Presentation
Effect of anti-coagulation in elderly patients with atrial fibrillation
23 April 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources